NCT00547053View on ClinicalTrials.gov

Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2011

Conditions
Cystic Fibrosis
Interventions
DRUG

Amiloride Solution for Inhalation

4.5 mL, Amiloride Solution for Inhalation, Inhaled via Omron Ultrasonic Nebulizer, TID, 6 months

Trial Locations (1)

02115

Children's Hospital, Boston

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

Boston Children's Hospital

OTHER

NCT00547053 - Amiloride Solution and Tobramycin Solution for Inhalation for the Eradication of Burkholderia Dolosa in Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter